search
Back to results

Single Anastomosis Versus Standard Duodenal Switch (SADI)

Primary Purpose

Obesity, Morbid Obesity

Status
Unknown status
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Standard Duodenal Switch
Single Anastomosis Duodenal Switch
Sponsored by
Laval University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity focused on measuring bariatric surgery

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age ≥18 years and ≤60 years
  • Fulfill criteria for bariatric surgery as coined by National Institutes of Health BMI≥35
  • Give written informed consent

Exclusion Criteria:

Participants who meet any of the following criteria at the time of the baseline visit are excluded from the study:

  • Presence of the following baseline comorbidities:
  • Inflammatory bowel disease (IBD),
  • Cirrhosis
  • History of gastric or duodenal ulcers
  • Preoperative hypoalbuminemia (<35 g/L)
  • History of severe renal, hepatic, cardiac or pulmonary disease
  • Past esophageal, gastric or bariatric surgery
  • Type 1 Diabetes
  • Pregnancy
  • Evidence of psychological problem that may affect the capacity to understand the project and to comply with the medical recommendations
  • History of drug use or alcohol abuse in the last 6 months
  • History of gastro-intestinal inflammatory diseases

Sites / Locations

  • Institut Universitaire de Cardiologie et de Pneumologie de QuébecRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

BPD-DS

SADI

Arm Description

Biliopancreatic diversion with Duodenal Switch (BPD-DS), with Sleeve gastrectomy, including a 100cm common channel and 150cm stric alimentary limb

Single-Anastomosis Duodeno-Ileal anastomosis (SADI) with Sleeve Gastrectomy, including a 250cm common channel

Outcomes

Primary Outcome Measures

Excess weight loss
Excess weight loss at 2 years of follow-up %EWL (Excess weight loss based on an ideal BMI = 25.) and change in BMI as compared to preoperative reference values
Rate of protein deficiency or insufficiency
Rate of protein deficiency (<35gr/l) or insufficiency (<30gr/l)
Mortality rate
Rate of mortality
BMI
change in BMI at 2 years follow-up as compared to preoperative reference values

Secondary Outcome Measures

Complication rate
overall and surgery-specific complications
Cure rate of comorbidities
Remission rate for comorbidities, including T2D, Hypertension, dyslipidemia, sleep apnea
Rate of minerals and vitamin deficiencies
Rate of deficiency and insufficiency in mineral and vitamins
Body composition by bioimpedance measures
body fat composition (%) assessed by biompedance
Change in quality of life
36-item short form survey score from 0 to 100
Change in quality of life
Bariatric Analysis and Reporting Outcomes System score from -7 to 9
Change in quality of life
Laval Questionnaire score from 0 to 7
Change in quality of life
GastroIntestinal Quality of Life Index from 0 to 144
Change in gatroesophageal reflux symptom
GastroEsophageal Reflus Disease Score from 0 to 72

Full Information

First Posted
March 23, 2018
Last Updated
February 21, 2021
Sponsor
Laval University
Collaborators
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
search

1. Study Identification

Unique Protocol Identification Number
NCT04767490
Brief Title
Single Anastomosis Versus Standard Duodenal Switch
Acronym
SADI
Official Title
Single Anastomosis Versus Standard Duodenal Switch - a Prospective Randomized Single-blinded Trial
Study Type
Interventional

2. Study Status

Record Verification Date
February 2021
Overall Recruitment Status
Unknown status
Study Start Date
September 1, 2015 (Actual)
Primary Completion Date
September 1, 2023 (Anticipated)
Study Completion Date
September 1, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Laval University
Collaborators
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Bilio-Pancreatic diversion with Duodenal Switch (BPD-DS) is the most effective bariatric procedure in terms of long-term weight loss and remission rate of Type 2 Diabetes. However, its technical difficulty and increased risk of long-term nutritional deficiencies have been a major hindrance to its diffusion. Recently, a " simplified " technique of Duodenal-Switch has been proposed by Sanchez-Pernaute et al. This technique involves the creation of a Sleeve Gastrectomy, transection of the first duodenum, and connection of the duodenum to an omega-loop of small bowel instead of a terminal intestinal loop used in standard BPD-DS. The overall objective of this study is to assess in a prospective randomized blinded trial, the outcomes of this new procedure, using a comprehensive clinical evaluation and follow-up method. This could potentially change the clinical practice and surgical approach in our Institution.
Detailed Description
Bilio-Pancreatic diversion with Duodenal Switch (BPD-DS) is the most effective bariatric procedure in terms of long-term weight loss and remission rate of Type 2 Diabetes. However, its technical difficulty and increased risk of long-term nutritional deficiencies have been a major hindrance to its diffusion. Our team, with more than 4000 BPD-DS performed since the early 1990's, is recognized internationally for its expertise with this specific procedure. Recently, a " simplified " technique of Duodenal-Switch has been proposed by Sanchez-Pernaute et al. This technique involves the creation of a Sleeve Gastrectomy, transection of the first duodenum, and connection of the duodenum to an omega-loop of small bowel instead of a terminal intestinal loop used in standard BPD-DS. This new procedure, called Single Anastomosis Duodenal Switch has the potential benefit of decreasing the complexity of the standard BPD-DS by avoiding one of the two intestinal anastomoses usually needed. This could potentially decrease the rate of peri-operative complications and increase access to this type of surgery. However, the length of the common channel (250cm) is more than doubled compared to standard BPD-DS, which could also change significantly the outcomes of the procedure itself. Indeed, the length of the common channel conditions the absorption of fat and fat-soluble vitamins. Currently, the scientific literature regarding this procedure is scarce, with only one author who published his 2-years outcomes, in a cohort study of 100 patients. In addition, this report presents major limitations. In example, the length of the omega loop was increased from 200 to 250cm during the course of the study, in order to decrease the rate of protein deficiency and reoperation for malnutrition. This and other limitations make it hard to assess the actual results of the technique. The overall objective of this study is to assess in a stronger study design (i.e. a prospective randomized single blinded trial), the outcomes of this new procedure, using a comprehensive clinical evaluation and follow-up method. This could potentially change the clinical practice and surgical approach in our Institution.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Morbid Obesity
Keywords
bariatric surgery

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
120 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
BPD-DS
Arm Type
Active Comparator
Arm Description
Biliopancreatic diversion with Duodenal Switch (BPD-DS), with Sleeve gastrectomy, including a 100cm common channel and 150cm stric alimentary limb
Arm Title
SADI
Arm Type
Experimental
Arm Description
Single-Anastomosis Duodeno-Ileal anastomosis (SADI) with Sleeve Gastrectomy, including a 250cm common channel
Intervention Type
Procedure
Intervention Name(s)
Standard Duodenal Switch
Other Intervention Name(s)
BPD-DS
Intervention Type
Procedure
Intervention Name(s)
Single Anastomosis Duodenal Switch
Other Intervention Name(s)
SADI
Primary Outcome Measure Information:
Title
Excess weight loss
Description
Excess weight loss at 2 years of follow-up %EWL (Excess weight loss based on an ideal BMI = 25.) and change in BMI as compared to preoperative reference values
Time Frame
2 years
Title
Rate of protein deficiency or insufficiency
Description
Rate of protein deficiency (<35gr/l) or insufficiency (<30gr/l)
Time Frame
from baseline up to 60 months
Title
Mortality rate
Description
Rate of mortality
Time Frame
from baseline up to 60 months
Title
BMI
Description
change in BMI at 2 years follow-up as compared to preoperative reference values
Time Frame
2 years
Secondary Outcome Measure Information:
Title
Complication rate
Description
overall and surgery-specific complications
Time Frame
from baseline up to 60 months
Title
Cure rate of comorbidities
Description
Remission rate for comorbidities, including T2D, Hypertension, dyslipidemia, sleep apnea
Time Frame
from baseline up to 60 months
Title
Rate of minerals and vitamin deficiencies
Description
Rate of deficiency and insufficiency in mineral and vitamins
Time Frame
from baseline up to 60 months
Title
Body composition by bioimpedance measures
Description
body fat composition (%) assessed by biompedance
Time Frame
from baseline up to 60 months
Title
Change in quality of life
Description
36-item short form survey score from 0 to 100
Time Frame
from baseline up to 60 months
Title
Change in quality of life
Description
Bariatric Analysis and Reporting Outcomes System score from -7 to 9
Time Frame
from baseline up to 60 months
Title
Change in quality of life
Description
Laval Questionnaire score from 0 to 7
Time Frame
from baseline up to 60 months
Title
Change in quality of life
Description
GastroIntestinal Quality of Life Index from 0 to 144
Time Frame
from baseline up to 60 months
Title
Change in gatroesophageal reflux symptom
Description
GastroEsophageal Reflus Disease Score from 0 to 72
Time Frame
from baseline to 60 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age ≥18 years and ≤60 years Fulfill criteria for bariatric surgery as coined by National Institutes of Health BMI≥35 Give written informed consent Exclusion Criteria: Participants who meet any of the following criteria at the time of the baseline visit are excluded from the study: Presence of the following baseline comorbidities: Inflammatory bowel disease (IBD), Cirrhosis History of gastric or duodenal ulcers Preoperative hypoalbuminemia (<35 g/L) History of severe renal, hepatic, cardiac or pulmonary disease Past esophageal, gastric or bariatric surgery Type 1 Diabetes Pregnancy Evidence of psychological problem that may affect the capacity to understand the project and to comply with the medical recommendations History of drug use or alcohol abuse in the last 6 months History of gastro-intestinal inflammatory diseases
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Suzy Laroche
Phone
418-656-8711
Ext
3841
Email
suzy_laroche@ssss.gouv.qc.ca
First Name & Middle Initial & Last Name or Official Title & Degree
Mélanie Nadeau, MSc
Phone
418-656-8711
Ext
3490
Email
melanie.nadeau@criucpq.ulaval.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Laurent Biertho, MD
Organizational Affiliation
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Official's Role
Principal Investigator
Facility Information:
Facility Name
Institut Universitaire de Cardiologie et de Pneumologie de Québec
City
Quebec City
State/Province
Quebec
ZIP/Postal Code
G1V 4G5
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Suzy Laroche
Phone
418-656-8711
Ext
3841
Email
suzy_laroche@ssss.gouv.qc.ca
First Name & Middle Initial & Last Name & Degree
Laurent Biertho, MD
First Name & Middle Initial & Last Name & Degree
Simon Marceau, MD
First Name & Middle Initial & Last Name & Degree
Simon Biron, MD
First Name & Middle Initial & Last Name & Degree
Stéfane Lebel, MD
First Name & Middle Initial & Last Name & Degree
François Julien, MD
First Name & Middle Initial & Last Name & Degree
Odette Lescelleur, MD
First Name & Middle Initial & Last Name & Degree
André Tchernof, MD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Single Anastomosis Versus Standard Duodenal Switch

We'll reach out to this number within 24 hrs